Results 31 to 40 of about 12,288 (265)

A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac [PDF]

, 2021
AbstractBackgroundPoor immunogenicity and antibody waning were found in vaccinees of CoronaVac. There is lack of randomized controlled trial (RCT) data to compare the immunogenicity and safety of schedules using homologous and heterologous vaccine as a booster dose.MethodsWe randomly assigned adults who had received 2 doses of CoronaVac with low ...
Chris Ka Pun Mok, Samuel M.S. Cheng, Chunke Chen, Karen Yiu, Tat-On Chan, Kiu Cheung Lai, Kwun Cheung Ling, Yuanxin Sun, Lun Lai Ho, Malik Peiris, David S Hui   +10 more
openaire   +1 more source

Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study

The Lancet Microbe, 2022
Summary: Background: Vaccination is an efficient strategy to control the COVID-19 pandemic. In north Cyprus, vaccine distribution started with CoronaVac followed by BNT162b2, and ChAdOx1 vaccines.
Burc Barin, MSc, Ulus Kasap, MSc, Ferda Selçuk, MD, Ender Volkan, PhD, Özge Uluçkan, PhD   +4 more
doaj   +1 more source

COVID‐19 vaccination acceptance: A case of interplay between political and health dimensions [PDF]

, 2023
Vaccines are essential for the eradication of diseases. Yet for many reasons, individuals do not embrace them completely. In the COVID- 19 pandemic and with the possibility of the Brazilian population’s immunization against the disease,
Bú, Emerson Do, DA SILVA LIMA, KALINE, Dantas Silva, Washington Allysson, P. Miranda, Mariana, Pereira, C.R.   +4 more
core   +1 more source

Humoral Immune Response to CoronaVac in Turkish Adults

Vaccines, 2023
While most approved vaccines are based on the viral spike protein or its immunogenic regions, inactivated whole-virion vaccines (e.g., CoronaVac) contain additional antigens that may enhance protection. This study analyzes short-term humoral responses against the SARS-CoV-2 spike (S1) and nucleocapsid (NCP) protein in 50 Turkish adults without previous
Yasemin Cosgun, Nergis Emanet, Ayten Öz Kamiloglu, Evelin Grage-Griebenow, Susann Hohensee, Sandra Saschenbrecker, Katja Steinhagen, Gulay Korukluoglu   +7 more
openaire   +3 more sources

Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong [PDF]

, 2022
Prior research using electronic health records for Covid-19 vaccine safety monitoring typically focuses on specific disease groups and excludes individuals with multimorbidity, defined as ≥2 chronic conditions. We examine the potential additional risk of
Chan, EWW, Chan, EWY, Chui, CSL, Huang, L, Lai, FTT, Leung, JCN, Li, X, Lum, DH, Luo, H, Ma, T, Wan, EYF, Wong, CKH, Wong, ICK   +12 more
core   +4 more sources

Intradermal ChAdOx1 Vaccine Following Two CoronaVac Shots: A Case Report [PDF]

Vaccines, 2021
Inactivated SARS-CoV-2 vaccines are used in many countries with uncertain immunogenicity. Intradermal ChAdOx1 has been proposed as a resource-efficient heterologous third booster shot. A 52-year-old healthy male healthcare professional had received two intramuscular CoronaVac shots on 21 April and 23 May 2021, and volunteered to take a 0.1 mL ChAdOx1 ...
Ekachai Singhatiraj, Krit Pongpirul, Anan Jongkaewwattana, Nattiya Hirankarn   +3 more
openaire   +3 more sources

Sobre a eficácia da CoronaVac no Twitter: conversações e aspectos políticos

Liinc em Revista, 2022
A CoronaVac, desenvolvida no Brasil pelo Instituto Butantan em parceria com a Sinovac, manteve-se em meio às disputas políticas que permearam o modo como o nosso país enfrentou a pandemia da COVID-19. Com o objetivo de mapear e compreender, em um período
Carina Luisa Ochi Flexor, Gustavo Costa, Vitória Lobo Batista Barros   +2 more
doaj   +1 more source

Dermatological adverse effects of COVID-19 vaccines

Turkderm Turkish Archives of Dermatology and Venereology, 2022
Studies for vaccine development have been completed in an unprecedented time to prevent further outbreak of the dangerous and potentially fatal coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2 ...
Elçin Akdaş, Nilsel İlter
doaj   +1 more source

Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines [PDF]

Revista da Sociedade Brasileira de Medicina Tropical, 2023
Background: Heterologous COVID-19 booster vaccination is an alternative strategy to homologous vaccination, especially in developing countries, due to shortages, delays, or unequal distribution of COVID-19 vaccines.
Serkan Atıcı, Ahmet Soysal, Erdem Gönüllü, Gökhan Aydemir, Naci Öner, Servet Alan, Havva Engin, Melek Yıldız, Metin Karaböcüoğlu   +8 more
doaj   +1 more source

GAMBARAN AWAL EFEK SAMPING VAKSIN SINOVAC-CORONAVAC PADA PETUGAS KESEHATAN DI KABUPATEN KEPULAUAN SANGIHE [PDF]

, 2022
Efek samping vaksin COVID-19 menjadi informasi yang sangat penting diketahui untuk meyakinkan masyarakat dalam rangka peningkatan cakupan vaksinasi. Penelitian ini bertujuan melakukan studi independen untuk mengetahui efek samping Sinovac-CoronaVac pada ...
Makahaghi, Yenny Budiman, Simanjorang, Chandrayani, Surudani, Conny Juliana   +2 more
core   +2 more sources